GE HealthCare Technologies (GEHC) drew investor focus after reporting second quarter 2026 earnings in line with its previously raised guidance, along with a new long term Catholic Health partnership and a planned CFO transition.

After the earnings release, GE HealthCare Technologies’ share price gained 4.89% on the day to $64.11. The 90 day share price return of 7.78% contrasts with a year to date share price decline of 22.59% and a 1 year total shareholder return that is down 17.35%, suggesting recent momentum has picked up after a weaker stretch.

If this earnings move has you thinking about opportunities linked to medical imaging and diagnostics, it could be a useful moment to look at other healthcare AI stocks via our screener, including the 40 healthcare AI stocks.

GE HealthCare Technologies now trades at a clear discount to both analyst targets and some intrinsic value estimates after this earnings pop. Is that simply market caution around execution and leadership changes, or a mispricing worth unpacking next?

Most Popular Narrative: 19.6% Undervalued

Against the last close of $64.11, the most followed narrative pegs GE HealthCare Technologies at a fair value of $79.72, implying meaningful upside in that framework.

The pipeline of new high-impact products, like Radiopharmaceuticals, Total Body PET, and Photon Counting CT, is anticipated to drive future revenue growth and potentially improve margins. The focus on expanding recurring revenue, particularly in areas like digital solutions and advanced visualization, is expected to contribute positively to revenue stability and net margins.

Curious what justifies that higher fair value for GE HealthCare Technologies? The narrative leans on steady revenue expansion, rising margins, and a future earnings multiple that differs from today. The detailed path from current earnings to that outlook is where the story gets interesting.

Result: Fair Value of $79.72 (UNDERVALUED)

However, GE HealthCare Technologies still faces tariff and China regulatory risks, along with competitive pressure in imaging and diagnostics that could challenge this undervaluation story.

Next Steps

With both risks and rewards in play for GE HealthCare Technologies, it makes sense to look at the full picture and move quickly to form your own view using the 4 key rewards and 1 important warning sign.

Looking for more investment ideas beyond GE HealthCare Technologies?

If this GE HealthCare Technologies update has sharpened your thinking, do not stop here. Use the tools available to quickly compare other potential opportunities side by side.

• Spot potential turnaround opportunities early by checking out 20 elite penny stocks with strong financials before they appear on everyone else's radar.
• Zero in on stocks that combine quality with appealing valuations by using the 49 high quality undervalued stocks so you are not overpaying for growth.
• Strengthen the foundation of your portfolio by reviewing the solid balance sheet and fundamentals stocks screener (48 results) and focus on companies that keep their finances in check.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.